"This latest trial suggests that [nivolumab plus AVD] may become the treatment of choice for all stages of Hodgkin's lymphoma." SWOG S1826 is a phase III, multicenter, randomized trial involving ...
Non-Hodgkin’s lymphoma is the 6 th most common malignancy among people in Sub-Saharan Africa and it is the 4 th most diagnosed cancer in men and the 5 th most diagnosed cancer in women in South ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback